The copy number of SMN2 represents one of the principal determinants of the severity of the SMA clinical phenotype, with higher copy numbers correlating with increased production of functional SMN protein and generally milder clinical manifestations [6]. Here, SMN2 is linked to proximal spinal muscular atrophy.